- Home
- BRAG vs QNCX Comparison
BRAG vs QNCX Comparison
Compare BRAG & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- QNCX
- Stock Information
- Founded
- BRAG 2018
- QNCX 2012
- Country
- BRAG Canada
- QNCX United States
- Employees
- BRAG N/A
- QNCX N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRAG Technology
- QNCX Health Care
- Exchange
- BRAG Nasdaq
- QNCX Nasdaq
- Market Cap
- BRAG 74.8M
- QNCX 85.9M
- IPO Year
- BRAG N/A
- QNCX 2019
- Fundamental
- Price
- BRAG $2.89
- QNCX $1.95
- Analyst Decision
- BRAG Buy
- QNCX Strong Buy
- Analyst Count
- BRAG 4
- QNCX 6
- Target Price
- BRAG $7.00
- QNCX $8.00
- AVG Volume (30 Days)
- BRAG 62.4K
- QNCX 371.2K
- Earning Date
- BRAG 11-13-2025
- QNCX 11-12-2025
- Dividend Yield
- BRAG N/A
- QNCX N/A
- EPS Growth
- BRAG N/A
- QNCX N/A
- EPS
- BRAG N/A
- QNCX N/A
- Revenue
- BRAG $123,209,630.00
- QNCX N/A
- Revenue This Year
- BRAG $6.62
- QNCX N/A
- Revenue Next Year
- BRAG $5.85
- QNCX N/A
- P/E Ratio
- BRAG N/A
- QNCX N/A
- Revenue Growth
- BRAG 10.90
- QNCX N/A
- 52 Week Low
- BRAG $2.59
- QNCX $0.69
- 52 Week High
- BRAG $6.12
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- BRAG 48.52
- QNCX 67.34
- Support Level
- BRAG $2.80
- QNCX $1.64
- Resistance Level
- BRAG $2.95
- QNCX $2.05
- Average True Range (ATR)
- BRAG 0.15
- QNCX 0.12
- MACD
- BRAG 0.03
- QNCX 0.03
- Stochastic Oscillator
- BRAG 45.61
- QNCX 78.25
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.